Feng Y, Cheng G, Wang H, Chen B
Department of Orthopedics, Ren Ji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Osteoporos Int. 2017 May;28(5):1641-1652. doi: 10.1007/s00198-017-3955-x. Epub 2017 Feb 20.
In this meta-analysis, we evaluated the association between serum 25-hydroxyvitamin D (25(OH) vitamin D) level and the risk of total fractures and hip fractures. Low serum 25(OH) vitamin D level is associated with an increased risk of total and hip fractures.
Data on the association between serum 25(OH) vitamin D level and the risk of fractures are conflicting. This study aimed to provide a summary of prospective cohort or nested case-control studies on the association between serum 25(OH) vitamin D level and the risk of total fractures and hip fractures.
We identified relevant studies by searching the PubMed, EMBASE, and OVID databases from their inception to June 1, 2016. We included published prospective cohort or nested case-control studies evaluating the associations of serum 25(OH) vitamin D level with the fracture risk. Two reviewers abstracted the data independently. Relative risks (RRs) with 95% confidence intervals (CIs) were derived throughout the whole analysis.
Sixteen prospective cohort studies and three nested case-control studies were included. We found that low serum 25(OH) vitamin D level was significantly associated with the risk of total fractures (RR 1.25, 95% CI 1.06-1.43; I = 31.3%, p for heterogeneity = 0.15) and hip fractures (RR 1.48, 95% CI 1.29-1.68; I = 0%, p for heterogeneity = 0.51). The hip fracture risk was increased by 40% for each SD decrease in serum 25(OH) vitamin D level (RR 1.40, 95% CI 1.20-1.61; I = 0%, p for heterogeneity = 0.51). The per SD decrease in serum 25(OH) vitamin D level was not associated with the increased risk of total fractures (RR 1.14, 95% CI 0.93-1.35; I = 63.2%, p for heterogeneity = 0.04).
Our study suggests that low serum 25(OH) vitamin D level is associated with increased risks of total and hip fractures. In the analyzed studies, the per SD decrease in serum 25(OH) vitamin D level was associated with the hip fracture risk but not with the total fracture risk.
在这项荟萃分析中,我们评估了血清25-羟维生素D(25(OH)维生素D)水平与总骨折及髋部骨折风险之间的关联。血清25(OH)维生素D水平较低与总骨折及髋部骨折风险增加相关。
关于血清25(OH)维生素D水平与骨折风险之间关联的数据存在矛盾。本研究旨在对血清25(OH)维生素D水平与总骨折及髋部骨折风险之间关联的前瞻性队列研究或巢式病例对照研究进行总结。
我们通过检索PubMed、EMBASE和OVID数据库,从其创建至2016年6月1日,确定相关研究。我们纳入已发表的前瞻性队列研究或巢式病例对照研究,评估血清25(OH)维生素D水平与骨折风险的关联。两名审阅者独立提取数据。在整个分析过程中得出相对风险(RR)及95%置信区间(CI)。
纳入16项前瞻性队列研究和3项巢式病例对照研究。我们发现,血清25(OH)维生素D水平较低与总骨折风险显著相关(RR 1.25,95% CI 1.06 - 1.43;I² = 31.3%,异质性p = 0.15)及髋部骨折风险显著相关(RR 1.48,95% CI 1.29 - 1.68;I² = 0%,异质性p = 0.51)。血清25(OH)维生素D水平每降低1个标准差,髋部骨折风险增加40%(RR 1.40,95% CI 1.20 - 1.61;I² = 0%,异质性p = 0.51)。血清25(OH)维生素D水平每降低1个标准差与总骨折风险增加无关(RR 1.14,95% CI 0.93 - 1.35;I² = 63.2%,异质性p = 0.04)。
我们的研究表明,血清25(OH)维生素D水平较低与总骨折及髋部骨折风险增加相关。在分析的研究中,血清25(OH)维生素D水平每降低1个标准差与髋部骨折风险相关,但与总骨折风险无关。